Structure-based prediction of MHC-peptide association: Algorithm comparison and application to cancer vaccine design

Journal of Molecular Graphics and Modelling

Volumn 26, Issue 3, 2007, Pages 667-675

  Schiewe, Alexandra J ^a   Haworth, Ian S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Epitope; HLA A2; KU CT 1; MHC; Peptide; Structure prediction

Indexed keywords

ALGORITHMS; BINDING ENERGY; IMMUNOLOGY; PEPTIDES; TUMORS; VACCINES;

CANCER IMMUNOTHERAPY; PEPTIDE VACCINATION; STRUCTURAL PREDICTION; STRUCTURE PREDICTION;

MOLECULAR STRUCTURE;

AMINO ACID DERIVATIVE; CANCER VACCINE; EPITOPE; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; DRUG STRUCTURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

ALGORITHMS; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; ARMADILLO DOMAIN PROTEINS; CANCER VACCINES; DRUG DESIGN; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A2 ANTIGEN; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SEQUENCE ANALYSIS, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; TESTICULAR NEOPLASMS;

EID: 34848824331     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2007.03.017     Document Type: Article

References (42)

1. Schuster M., Nechansky A., and Kircheis R. Cancer immunotherapy. Biotechnol. J. 1 (2006) 138-147
2. Huber C.H., and Wolfel T. Immunotherapy of cancer: from vision to standard clinical practice. J. Cancer Res. Clin. Oncol. 130 (2004) 367-374
3. Evel-Kabler K., and Chen S.Y. Dendritic cell-based tumor vaccines and antigen presentation attenuators. Mol. Ther. 13 (2006) 850-858
4. Tey S.K., Bollard C.M., and Heslop H.E. Adoptive T-cell transfer in cancer immunotherapy. Immunol. Cell Biol. 84 (2006) 281-289
5. Rosenberg S.A., Sherry R.M., Morton K.E., Yang J.C., Topalian S.L., Royal R.E., Kammula U.S., Restifo N.P., Hughes M.S., Schwarz S.L., Ngo L.T., Mavroukakis S.A., and White D.E. Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines. J. Immunother. 29 (2006) 224-231
6. Romero P., Cerottini J.-C., and Speiser D.E. Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination. Cancer Immunol. Immunother. 53 (2004) 249-255
7. Abbas A.K., and Lichtman A.H. Cellular and Molecular Immunology (2005), Elsevier Sauders, Philadelphia, PA
8. Rudolph M.G., Stanfield R.L., and Wilson I.A. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24 (2006) 419-466
9. Madden D.R. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13 (1995) 587-622
10. Davenport M.P., Smith K.J., Barouch D., Reid S.W., Bodnar W.M., Willis A.C., Hunt D.F., and Hill A.V. HLA class I binding motifs derived from random peptide libraries differ at the COOH terminus from those of eluted peptides. J. Exp. Med. 185 (1997) 367-371
11. Meng W.S., and Butterfield L.H. Rational design of peptide-based tumor vaccines. Pharm. Res. 19 (2002) 926-932
12. Kuhns J.J., Batalia M.A., Yan S., and Collins E.J. Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide. J. Biol. Chem. 274 (1999) 36422-36427
13. Tanaka Y., Amos K.D., Joo H.G., Eberlein T.J., and Goedegebuure P.S. Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes. Int. J. Cancer 94 (2001) 540-544
14. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., and Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50 (1999) 213-219
15. Parker K.C., Bednarek M.A., Hull L.K., Utz U., Cunningham B., Zweerink H.J., Biddison W.E., and Coligan J.E. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 149 (1992) 3580-3587
16. Brusic V., Rudy G., and Harrison L.C. Prediction of MHC binding peptides using artificial neural networks. Complex Systems: Mechanism of Adaptation (1994), IOS Press, Amsterdam 253-260
17. Adams H.P., and Koziol J.A. Prediction of binding to MHC class I molecules. J. Immunol. Methods 185 (1995) 181-190
18. Milik M., Sauer D., Brunmark A.P., Yuan L., Vitiello A., Jackson M.R., Peterson P.A., Skolnick J., and Glass C.A. Application of an artificial neural network to predict specific class I MHC binding peptide sequences. Nat. Biotechnol. 16 (1998) 753-756
19. Doytchinova I.A., and Flower D.R. Towards the quantitative prediction of T-cell epitopes: CoMFA and CoMSIA studies of peptides with affinity for the class I MHC molecule HLA-A*0201. J. Med. Chem. 44 (2001) 3572-3581
20. Schueler-Furman O., Altuvia Y., Sette A., and Margalit H. Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles. Protein Sci. 9 (2000) 1838-1846
21. Desmet J., Meersseman G., Boutonnet N., Pletinckx J., De Clercq K., Debulpaep M., Braeckman T., and Lasters I. Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validation. Proteins 58 (2005) 53-69
22. Altuvia Y., and Margalit H. A structure-based approach for prediction of MHC-binding peptides. Methods 34 (2004) 454-459
23. Singh H., and Raghava G.P.S. ProPred1: prediction of promiscuous MHC class-I binding sites. Bioinformatics 19 (2003) 1009-1014
24. Peters B., Tong W., Sidney J., Sette A., and Weng Z. Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics 19 (2003) 1765-1772
25. Buus S., Lauemoller S.L., Worning P., Kesmir C., Frimurer T., Corbet S., Fomsgaard A., Hilden J., Holm A., and Brunak S. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 62 (2003) 378-384
26. Guan P., Doytchinova I.A., Zygouri C., and Flower D.R. MHCPred: bringing a quantitative dimension to the online prediction of MHC binding. Appl. Bioinform. 2 (2003) 63-66
27. Smith K.J., Reid S.W., Harlos K., McMichael A.J., Stuart D.I., Bell J.I., and Jones E.Y. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4 (1996) 215-228
28. Meng W.S., von Grafenstein H., and Haworth I.S. A model of water structure inside the HLA-A2 peptide binding groove. Int. Immunol. 9 (1997) 1339-1346
29. Meng W.S., von Grafenstein H., and Haworth I.S. Water dynamics at the binding interface of four different HLA-A2-peptide complexes. Int. Immunol. 12 (2000) 949-957
30. Bui H.-H., Schiewe A.J., von Grafenstein H., and Haworth I.S. Structural prediction of peptides binding to MHC class I molecules. Proteins 63 (2006) 43-52
31. H.-H. Bui, A.J. Schiewe, I.S. Haworth, WATGEN: an algorithm for modeling water networks at protein-protein binding interfaces. J. Comp. Chem., in press.
32. Okada T., Akada M., Fujita T., Iwata T., Goto Y., Kido K., Okada T., Matsuzaki Y., Kobayashi K., Matsuno S., Sunamura M., and Kawakami Y. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers. Clin. Cancer Res. 12 (2006) 191-197
33. Clark C.E., and Vonderheide R.H. Cancer-testis antigens in tumor biology and immunotherapy. Cancer Biol. Ther. 5 (2006) 1226-1227
34. Doytchinova I.A., and Flower D.R. Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study. Proteins 48 (2002) 505-518
35. Bednarek M.A., Sauma S.Y., Gammon M.C., Porter G., Tamhankar S., Williamson A.R., and Zweerink H.J. The minimum peptide epitope from the influenza virus matrix protein. J. Immunol. 127 (1991) 4047-4053
36. Madden D.R., Garboczi D.N., and Wiley D.C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75 (1993) 693-708
37. Gulukota K., Sidney J., Sette A., and DeLisi C. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J. Mol. Biol. 267 (1997) 1258-1267
38. Bhasin M., and Raghava G.P. Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 22 (2004) 3195-3204
39. Mallios R.R. A consensus strategy for combining HLA-DR binding algorithms. Hum. Immunol. 64 (2003) 852-856
40. Yu K., Petrovsky N., Schonbach C., Koh J.Y., and Brusic V. Methods for prediction of peptide binding to MHC molecules: a comparative study. Mol. Med. 8 (2002) 137-148
41. Peters B., Bui H.-H., Franklid S., Nielsen M., Lundegaard C., Kostem E., Basch D., Kasper L., Harndahl M., Fleri W., Wilson S.S., Sidney J., Lund O., Buus S., and Sette A. A community resource benchmarking prediction of peptide binding to MHC-I molecules. PLoS Comp. Biol. 2 (2006) e65
42. Petrone P.M., and Garcia A.E. MHC-peptide binding is assisted by bound water molecules. J. Mol. Biol. 338 (2004) 419-435